Depletion of protein kinase C? in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression
Open Access
- 6 June 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (6) , 1370-1381
- https://doi.org/10.1002/1529-0131(200106)44:6<1370::aid-art230>3.0.co;2-2
Abstract
Objective To determine whether the extracellular matrix protein tenascin‐C (TN‐C) is overexpressed in lung fibroblasts from systemic sclerosis (SSc) patients, the molecular mechanisms regulating TN‐C secretion in SSc and normal lung fibroblasts, and how these processes might contribute to lung fibrosis in SSc patients. Methods TN‐C secretion by SSc and normal fibroblasts was compared in vivo (in bronchoalveolar lavage [BAL] fluid) and in vitro (in culture medium). The ability of thrombin to induce TN‐C was confirmed at both the protein and the messenger RNA (mRNA) level. The role of protein kinase Cε (PKCε) in the expression of TN‐C was evaluated by determining the effects of thrombin on PKCε levels and by directly manipulating PKCε levels via the use of antisense oligonucleotides. Results BAL fluid from SSc patients contained high levels of TN‐C, whereas that from normal subjects contained little or no TN‐C. In vitro, SSc lung fibroblasts expressed much higher amounts of TN‐C than did normal lung fibroblasts. Consistent with the idea that thrombin is a physiologic inducer of TN‐C, thrombin stimulated TN‐C mRNA and protein expression in both SSc and normal lung fibroblasts by a mechanism that required proteolytic cleavage of the thrombin receptor. Surprisingly, thrombin treatment and antisense oligonucleotide–mediated depletion of PKCε indicated that TN‐C expression is regulated via opposite signaling mechanisms in SSc and normal cells. In SSc lung fibroblasts, thrombin decreased PKCε levels, and the decreased PKCε induced TN‐C secretion; in normal fibroblasts, thrombin increased PKCε levels, and the increased PKCε induced TN‐C secretion. Normal and SSc lung fibroblasts also differed in the subcellular localization of PKCε, both before and after thrombin treatment. Conclusion These studies are the first to demonstrate that thrombin is a potent simulator of TN‐C in lung fibroblasts and that PKCε is a critical regulator of TN‐C protein levels in these cells. Furthermore, our results indicate that both the regulation of PKCε levels by thrombin and the regulation of TN‐C levels by PKCε are defective in SSc lung fibroblasts.Keywords
This publication has 43 references indexed in Scilit:
- IL-4 Upregulates Tenascin Synthesis in Scleroderma and Healthy Skin FibroblastsJournal of Investigative Dermatology, 1996
- Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue.Annals of the Rheumatic Diseases, 1996
- PKC α regulates thrombin‐induced PDGF‐B chain gene expression in mesangial cellsFEBS Letters, 1995
- Selective Inhibition of Thrombin Receptor-mediated Ca2+ Entry by Protein Kinase C βJournal of Biological Chemistry, 1995
- Tenascins, a growing family of extracellular matrix proteinsCellular and Molecular Life Sciences, 1995
- Tenascin immunoreactivity in cryptogenic fibrosing alveolitisThe Journal of Pathology, 1995
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization.The Journal of cell biology, 1993
- Thrombin-Mediated Increase in Vascular Endothelial PermeabilitySeminars in Thrombosis and Hemostasis, 1992
- Cell type-specific control of human neuronectin secretion by polypeptide mediators and phorbol ester.Journal of Histochemistry & Cytochemistry, 1989